Overview

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

Status:
NOT_YET_RECRUITING

Trial end date:
2026-02-01

Target enrollment:

Participant gender:

Summary

This study is an open-label, fixed-sequence, self-controlled Phase I clinical trial conducted among obese or overweight subjects, with a planned enrollment of 40 adult subjects.

Phase:

PHASE1

Details

Lead Sponsor:

Shandong Suncadia Medicine Co., Ltd.

Treatments:

Acetaminophen
Digoxin
Rosuvastatin Calcium